Mutaciones
Title: PTI+: Mutation screening based on their potential biological relevance
Research groups: Viral Biology and Evolutionary Systems Virology
We are assessing the effects of different SARS-CoV-2 variants and mutations on evasion from antivirals and immune responses, as well as their effects on infectivity and stability. We are employing pseudotype systems as well as replication competent VSV encoding the SARS-CoV-2 spike protein.
Santiago Elena (CSIC, I2SysBio)
Iñaki Comas (IBV, CSIC)
Carmen Gil (CIB, CSIC)
David Rios (ICMAT, CSIC)
Alberto Marina (IBV, CSIC)
José Carazo (CNB, CSIC)
European Commission – NextGenerationEU
“This contract/assignment is financed by the European Union Recovery Instrument, established by the Council Regulation (EU) 2020/2094 of 14 December 2020 establishing a European Union Recovery Instrument to support the recovery in the aftermath of the COVID-19 crisis, and regulated according to Regulation (EU) 2021/241 of the European Parliament and of the Council of 12 February 2021 establishing the Recovery and Resilience Facility”.
Instituto de Biomedicina de Valencia
Centro de Investigaciones Biológicas
Instituto de Ciencias Matemáticas
Centro Nacional de Biotecnología